CClinicalTrials.gg
Not yet recruitingNCT07511946OSA BruxismUpdated Jul 22, 2026

Bruxism Induced by Obstructive Sleep Apnoea.

An observational study in Sleep Apnea Syndrome, Obstructive, Bruxism, Sleep-Related and Upper Respiratory Tract Illness, sponsored by Wroclaw Medical University. Not yet recruiting at 1 site in Poland. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-22.

Sponsored by Wroclaw Medical University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
80
Ages
18 Years and older
Sex
All
01

Study summary

The relationship between obstructive sleep apnea (OSA), sleep bruxism, and temporomandibular disorders is becoming clearer, but data on how upper airway volume affects bruxism due to OSA is limited. Recent studies have shown that Cone-Beam Computed Tomography (CBCT) accurately images the upper airway, enabling analysis of its volume and its potential impact on bruxism. CBCT uses low radiation doses, significantly lower than harmful levels, making it a safe method for such assessments. Understanding these relationships can inform clinical practices for managing sleep bruxism, which affects 21% of the global population. The study aims to explore how upper airway volume influences the intensity of sleep bruxism related to OSA.

Read the detailed description

The main objective of the study is to assess the relationship between upper airway volume and sleep bruxism and obstructive sleep apnea. The following null hypothesis was adopted: upper airway volume influences the intensity of sleep bruxism induced by obstructive sleep apnea.

The relationship between obstructive sleep apnea and bruxism during sleep (behavior involving increased activity of the masticatory muscles during sleep) and temporomandibular disorders (a group of diseases and disorders related to the morphology and function of the masticatory system (mainly the temporomandibular joints and masticatory muscles) is becoming increasingly well understood. However, there is a lack of data on the relationship between the three-dimensional volume of the upper airways and sleep bruxism induced by sleep apnea. Recent scientific publications have demonstrated the ability of CBCT (Cone-Beam Computed Tomography) to image the upper airway very accurately in order to examine the minimum cross-section and total volume of the upper airway in three dimensions. 3D imaging using CBCT is a simple, effective, and safe method for accurate analysis of the upper airway, which will help determine the relationship between upper airway volume and bruxism induced by obstructive sleep apnea (OSA). Modern cone beam tomography is characterized by significantly lower doses of electromagnetic radiation, averaging between 0.05 and 0.6 mSv (50-600 µSv). It is estimated that, on average, each person receives a dose of radiation from natural sources of approximately 2.4 mSv (2,400 µSv) per year. Radiation doses in diagnostic imaging, therefore, represent only a fraction of these values. It is important to be aware of what dose of radiation is harmful. It is estimated that negative health effects may occur at doses of around 200 mSv (200,000 µSv), which is significantly higher than that received during modern imaging examinations.

Materials and Methods:

A total of 80 adult volunteers will be recruited for the research project, divided into two groups of 40 each, comprising both sexes, who will give their voluntary and informed consent to participate in the study. The study group will consist of patients with sleep bruxism and obstructive sleep apnoea. The control group will consist of patients with sleep bruxism without obstructive sleep apnoea. First, each potential participant in the project will undergo a clinical and physical examination of the stomatognathic system in accordance with the international DC/TMD guidelines (Diagnostic Criteria for Temporomandibular Disorders) and in accordance with the current international consensus on bruxism at the Temporomandibular Disorders Clinic of the University Dental Centre in Wrocław. The patient will undergo a clinical examination during which systemic diseases and medications taken will be recorded.

The study will also include a range of validated questionnaires assessing psycho-emotional well-being and selected aspects related to the functioning of the stomatognathic system, including the PHQ-9 (Patient Health Questionnaire 9), PSS-10 (Perceived Stress Scale 10), GAD-7 (Generalised Anxiety Disorder 7), SWLS (Satisfaction with Life Scale), SSS-8 (Somatic Symptom Scale 8), MIDAS (The Migraine Disability Assessment Test), JFLS-8 (Jaw Functional Limitation Scale - 8), TMD Pain Screener (Temporomandibular Disorders Pain Screener) and DC/TMD Symptom Questionnaire (Diagnostic Criteria for Temporomandibular Disorders Symptom Questionnaire). In addition, the following validated sleep questionnaires will be used: EPWORTH (Epworth Sleepiness Scale), PSQI (Pittsburgh Sleep Quality Index) and STOP-Bang Questionnaire. The next step will be to refer the patient for CBCT imaging, including measurements of the minimum cross-sectional area and 3D volume of the upper airways. Upper airway measurements will be performed in accordance with the protocol by Fonseca et al. The CBCT scan will take place at the University Dental Centre in Wrocław. The patient will then be referred to the Department and Clinic of Diabetology, Hypertension and Internal Medicine at the University Hospital, 213 Borowska Street, Wrocław, for a polysomnography examination. Polysomnography (PSG) is a non-invasive test comprising an EEG (electroencephalogram), ECG (electrocardiogram), EOG (electrooculogram), EMG (electromyogram), assessment of chest and abdominal movements, and measurement of blood oxygen saturation. It is used as the gold standard for diagnosing the severity of sleep apnoea by determining the AHI (Apnoea-Hypopnoea Index) and sleep bruxism by determining the BEI (Bruxism Episode Index). The polysomnography will be performed in accordance with the current guidelines of the American Academy of Sleep Medicine. During PSG, numerous other parameters relating to bodily functions during sleep are also collected. The aforementioned medical facilities possess the necessary equipment, scientific and clinical knowledge and experience to carry out the aforementioned examinations (CBCT: Planmeca Viso G7 CT scanner, Helsinki, Finland; PSG: NOX A1 sleep recorder, Iceland). The collected data will undergo thorough and specialist statistical analysis.

Anticipation Results:

By analyzing the results collected during the study and establishing probable correlations or their absence, it will be possible to understand the relationship between specific disorders and behaviors, and then counteract their development in everyday clinical work with patients with sleep bruxism around the world. According to the latest meta-analysis, this is 21% of the global population.

02

Conditions studied

  • Sleep Apnea Syndrome, Obstructive
  • Bruxism, Sleep-Related
  • Upper Respiratory Tract Illness

Keywords

  • Sleep Apnea
  • Bruxism, Sleep-Related
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

A total of 80 adult volunteers will be recruited for the research project, divided into two groups of 40 each, comprising both sexes, who will give their voluntary and informed consent to participate in the study. The study group will consist of patients with sleep bruxism and obstructive sleep apnoea. The control group will consist of patients with sleep bruxism without obstructive sleep apnoea. Participants are arbitrarily selected from a population.

Inclusion criteria

  • age equal to/greater than 18 years
  • moderate or high risk of sleep apnea according to the STOP-Bang questionnaire
  • presence of bruxism symptoms in the oral cavity according to the current international consensus on bruxism
  • positive history of bruxism during sleep

Exclusion criteria

Exclusion Criteria:

  • refusal to participate in the study
  • pregnancy
  • breastfeeding
  • presence of severe mental illness
  • alcohol and/or drug addiction
  • taking medications that affect the neuromuscular and/or respiratory systems
  • severe systemic diseases such as cancer
  • severe neurological and autoimmune diseases
  • multiple missing teeth
  • edentulism in the upper and/or lower jaw
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
80 participants (estimated)
Patient registry
No

Groups and cohorts

  • Study Group

    The study group will consist of patients with sleep bruxism and obstructive sleep apnoea. Participants will be examined based on the standardised international protocol Diagnostic Criteria for Temporomandibular Disorders (DC/TMD). Study participants will complete the following validated questionnaires assessing their psycho-emotional state and selected aspects related to the function of the stomatognathic system, including PHQ-9, PSS-10, GAD-7, SWLS, SSS-8, MIDAS, JFLS-8, TMD Pain Screener and DC/TMD Symptom Questionnaire (Diagnostic Criteria for Temporomandibular Disorders Symptom Questionnaire). In addition, the following validated sleep questionnaires will be used: EPWORTH ,PSQI and STOP-Bang Questionnaire. Subsequently, CBCT computed tomography will be performed along with polysomnography to determine the parameters of upper airway volume and sleep apnea.

    Diagnostic Test: Upper airway volume assessment using Cone-Beam Computed Tomography (CBCT) and Polysomnography

  • Control Group

    The control group will consist of patients with sleep bruxism. Participants will be examined based on the standardised international protocol Diagnostic Criteria for Temporomandibular Disorders (DC/TMD). Study participants will complete the following validated questionnaires assessing their psycho-emotional state and selected aspects related to the function of the stomatognathic system, including PHQ-9, PSS-10, GAD-7, SWLS, SSS-8, MIDAS, JFLS-8, TMD Pain Screener and DC/TMD Symptom Questionnaire (Diagnostic Criteria for Temporomandibular Disorders Symptom Questionnaire). In addition, the following validated sleep questionnaires will be used: EPWORTH ,PSQI and STOP-Bang Questionnaire. Subsequently, CBCT computed tomography will be performed to determine the parameters of upper airway volume.

    Diagnostic Test: Upper airway volume assessment using Cone-Beam Computed Tomography (CBCT)

Interventions

  • Diagnostic testUpper airway volume assessment using Cone-Beam Computed Tomography (CBCT) and Polysomnography

    Patients in the study group will undergo validated questionnaires assessing psycho-emotional well-being and selected aspects related to the functioning of the stomatognathic system, upper airway volume assessment using CBCT tomography and polysomnography.

  • Diagnostic testUpper airway volume assessment using Cone-Beam Computed Tomography (CBCT)

    Patients in the control group will undergo validated questionnaires assessing psycho-emotional well-being and selected aspects related to the functioning of the stomatognathic system, upper airway volume assessment using CBCT tomography.

05

What researchers measure

Primary outcomes

  1. The relationship between obstructive sleep apnea and bruxism during sleep.

    Relationship between the three-dimensional volume of the upper airways and sleep bruxism induced by sleep apnea, determined by CBCT and polysomnography.

    Time frame: 01.04.2026-31.11.2026

Secondary outcomes

  1. Relationship between masticatory muscle pain and depression assessed by Patient Health Questionnaire.

    Each participant will fill in Patient Health Questionnaire - 9. PHQ-9 total score for the nine items ranges from 0 to 27.Scores of 5, 10, 15, and 20 represent cutpoints for mild, moderate, moderately severe and severe depression, respectively.

    Time frame: 01.04.2026-31.12.2026

  2. Relationship between masticatory muscle pain and anxiety assessed by Generalized Anxiety Disorder -7.

    Each participant will fill in Generalized Anxiety Disorder -7 that consists of 7 items. Total score ranges 0-21 points. Scores of 5, 10, and 15 are taken as the cut-off points for mild, moderate and severe anxiety, respectively.

    Time frame: 01.04.2026-31.12.2026

  3. Relationship between masticatory muscle pain and perceived stress assessed by Perceived Stress Scale.

    Each participant will fill in Perceived Stress Scale -10. Scores are obtained by reversing the scores on the four positive items, e.g., 0=4, 1=3, 2=2, etc. and then summing across all 10 items. Items 4,5, 7, and 8 are the positively stated items. It can range from 0 to 40. Scores ranging from 0-13 would be considered low stress,14-26 would be considered moderate stress, 27-40 would be considered high perceived stress.

    Time frame: 01.04.2026-31.12.2026

  4. Relationship between masticatory muscle pain and satisfaction with life assessed by Satisfaction With Life Scale.

    Each participant will fill in Satisfaction With Life Scale which consist of five questions with 5 possible answers. Total score range is 35. Higher score represents higher life satisfaction. Score ranging from 5-9 as considered as extremly dissatisfied with life, 10-14 dissatisfied, 15-19 slightly dissatisfied, 20-24 slightly satisfied, 25-29 satisfied, 30-35 extremely satisfied.

    Time frame: 01.04.2026-31.12.2026

  5. Relationship between bruxism and sleep quality assessed by Pittsburgh Sleep Quality Index - a self-report questionnaire that assesses sleep quality over a 1-month time interval.

    Each participant will fill in Pittsburgh Sleep Quality Index. The measure consists of 19 individual items, creating 7 components that produce one global score ranging from 0 to 21, where lower scores mean better sleep quality.

    Time frame: 01.04.2026-31.12.2026

  6. Relationship between bruxism and apnea risk assessed by STOP-Bang.

    Each participant will fill in STOP-Bang questionnaire. The total score ranges from 0 to 8. The lower the score is, the lower the risk of occurrence Obstructive Sleep Apnea (OSA).

    Time frame: 01.04.2026-31.12.2026

  7. Relationship between bruxism and headache impact assessed by Migraine Disability Assessment questionnaire.

    Each participant will fill in Migraine Disability Assessment questionnaire. Scoring includes adding the total number of days from questions 1-5. Grading includes: grade I (little or no disability) 0-5 days, grade II (mild disability) 6-10 days, grade III (moderate disability) 11-20 days, grade IV (severe disability) more than 21 days.

    Time frame: 01.04.2026-31.12.2026

  8. Relationship between bruxism and sleep apnea (OSA) by Epworth Sleepiness Scale

    Each participant will fill Epworth Sleepiness Scale (ESS), which is a validated 8-item self-administered questionnaire used to measure average daytime sleepiness and the probability of falling asleep in common situations, ranging from 0 (never) to 3 (high chance) per item. A total score of 11 or higher indicates excessive daytime sleepiness, potentially suggesting sleep disorders like apnea.

    Time frame: 01.04.2026-31.12.2026

06

Study locations

1 site
  • Uniwersyteckie Centrum Stomatologiczne
    Wroclaw, Dolny Śląsk 50-425, Poland
07

References and documents

Publications

  • Oksenberg A, Arons E. Sleep bruxism related to obstructive sleep apnea: the effect of continuous positive airway pressure. Sleep Med. 2002 Nov;3(6):513-5. doi: 10.1016/s1389-9457(02)00130-2. PubMed 14592147 ↗

Individual participant data

Plan to share: No

08

Registry details

Key details

Study ID
NCT07511946
Lead sponsor
Wroclaw Medical University
Responsible party
Sponsor
First posted
Apr 6, 2026
Start date
Sep 2026 (estimated)
Primary completion
Oct 2026 (estimated)
Completion
Nov 2026 (estimated)
Last update
Jul 22, 2026

Study contacts

Andrzej Małysa, PhD
Contact
andrzej.malysa@umw.edu.pl
7717186292 ext. +48
Mieszko Więckiewicz, Professor MD, PhD, DSc
Contact
mieszko.wieckiewicz@umw.edu.pl
7717186292 ext. +48
Mieszko Adam Więckiewicz, Professor MD, PhD, DSc
principal investigator · Wroclaw Medical University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion